Delivery Order SPE2DR25D2106-SPE2DR26F1GCD
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,365.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector pharmaceutical supplies. This non-set-aside award, issued on August 25, 2025, with completion targeted for August 26, 2025, represents a single delivery transaction under AmerisourceBergen's existing DLA contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,903.37 to AmerisourceBergen Drug Corp for XYOSTED 75 MG/0.5 ML auto-injector supplies (0.5ML). This non-competitive, firm fixed-price delivery order was awarded on December 10, 2025, with an ultimate completion date of December 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contractual...
- The Defense Logistics Agency awarded a delivery order valued at $1,950.54 to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector units on October 23, 2025, with completion scheduled for October 24, 2025. This competitively awarded, firm fixed-price delivery order represents a medical pharmaceutical supply to support federal healthcare operations. The product will be delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $1,561.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector units. The contract, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Xyosted 100 mg/0.5 mL auto-injector units valued at $1,722.90, with an ultimate completion date of January 2, 2026. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed from...
- The Defense Logistics Agency (DLA) awarded a $1,629.66 delivery order to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector supplies on May 8, 2025, with completion scheduled for May 9, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen's Corporate Office...
- The Defense Logistics Agency awarded a delivery order valued at $1,204.01 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector supplies on November 3, 2025, with completion expected by November 4, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded transaction for pharmaceutical supplies to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered...
- The Defense Logistics Agency awarded a $1,218.87 delivery order to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 ml auto-injector vials, with a completion date of December 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's existing indefinite delivery contract vehicle. The product will be performed and delivered from the contractor's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,257.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injector supplies on December 3, 2025, with completion targeted for December 4, 2025. This non-set-aside award represents a small-value transaction under AmerisourceBergen's broader relationship with DLA for pharmaceutical and medical supply distribution. The delivery location is the vendor's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for XYOSTED 75 MG/0.5 ML auto-injector supplies valued at $5,675.20 on December 3, 2025, with completion expected by December 4, 2025. This competitively awarded, firm fixed price delivery order represents AmerisourceBergen's continued role as a critical pharmaceutical supplier to federal medical procurement needs. The contract is not set-aside and performs out of the vendor's corporate office location in...
- SPE2DR25D2106Indefinite Delivery Contract
- SPE2DR25D2106-SPE2DR26F1GCDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,436.85 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector supplies on December 30, 2025, with completion scheduled for December 31, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply portfolio supporting federal medical procurement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs, including medications, vaccines, and specialized medical devices across multiple therapeutic domains. The contract serves critical federal customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key pharmaceutical distributor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/29/25 |